Key Record Dates
ClinicalTrials.gov Identifier: | NCT05217446 |
---|---|
Brief Title: | A Study of Encorafenib Plus Cetuximab Taken Together With Pembrolizumab Compared to Pembrolizumab Alone in People With Previously Untreated Metastatic Colorectal Cancer (SEAMARK) |
First Submitted : | January 19, 2022 |
First Submitted that Met QC Criteria : | January 19, 2022 |
First Posted : | February 1, 2022 |
Last Update Submitted that Met QC Criteria : | May 30, 2023 |
Last Update Posted : | June 1, 2023 |